Brief: Rallybio Q1 Net Income USD -19.029 Million
09/05/2024 13:00
May 09 (Reuters) - Rallybio Q1 income from operations USD -19.787 million. * Q1 basic EPS USD -0.47 * Q1 operating expenses USD 19.787 million
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx